Delivery Order SPE2DR25D1202-SPE2DR26F72CV
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $104,511.07 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed-price contract, which was not set-aside and competitively awarded, was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) at a ceiling value of $2,378.33. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 29, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,513.59 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Gemtesa 75 mg tablets (90 count). The award represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-competitive set-aside award was made through the Defense Logistics Agency's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order valued at $86,421.37 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for October 29, 2025, and fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.18 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $58,668.40 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $48,882.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units) with a performance location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-asides and carries an ultimate completion date of August 18, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $7,959.64 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Gemtesa 75 mg tablets (90-count units) under a firm fixed-price contract. The order, valued at $11,462.54, was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $10,816.44 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72CVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,855.72 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience supplying a wide range of pharmaceuticals and medical commodities across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical devices. This particular delivery order for Gemtesa, a urological medication, exemplifies the vendor's ongoing role in supporting military medical procurement through the DLA's pharmaceutical supply chain, with pricing established through firm fixed-price mechanisms typical of DLA delivery order competitively awarded transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/12/25 |